• Je něco špatně v tomto záznamu ?

Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe

R. Kukla, K. Nouzovska, L. Ryskova, P. Rozsivalova, I. Pavlik, P. Bostik

. 2024 ; 23 (1) : 92. [pub] 20241009

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003912

Grantová podpora
MH-CZ DRO (UHHK, 00179906) Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906) Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906) Ministerstvo Zdravotnictví Ceské Republiky
MH-CZ DRO (UHHK, 00179906) Ministerstvo Zdravotnictví Ceské Republiky
NU20-09-00114 Agentura Pro Zdravotnický Výzkum České Republiky
NU20-09-00114 Agentura Pro Zdravotnický Výzkum České Republiky

INTRODUCTION AND PURPOSE: Mycobacterium (M.) chelonae is responsible for a half of relatively rare nontuberculous mycobacteria (NTM) keratitis. We report a case of M. chelonae keratitis in a woman following sclerocorneal suture extraction after cataract surgery. RESULTS: A 70-year-old woman presented with a red eye and corneal infiltration of her left eye six weeks following sclerocorneal suture extraction after an elective cataract surgery in another institute. She complained of a sharp, cutting pain and photophobia. Since initial corneal scrapes and conjunctival swabs proved no pathogen using culture and PCR methods, non-specific antibiotics and antifungal agents were administered. As keratitis was complicated by an inflammation in the anterior chamber and vitreous, samples of the vitreous fluid were sent for microbiologic examination. DNA of Epstein-Barr virus (EBV) was repeatedly detected. Since the intrastromal abscess had formed, corneal re-scrapings were performed and M. chelonae was detected using culture, MALDI-TOF MS and PCR methods. Therapy was changed to a combination of oral and topical clarithromycin, intravitreal, topical and intracameral amikacin, and oral and topical moxifloxacin. The successful therapy led to stabilization. The optical penetrating keratoplasty was performed and no signs of the infection recurrence were found. CONCLUSIONS: The diagnosis of nontuberculous mycobacterial keratitis is difficult and often delayed. An aggressive and prolonged antimicrobial therapy should include systemic and topical antibiotics. Surgical intervention in the form of corneal transplantation may be required in the active and nonresponsive infection. In the presented case this was necessary for visual rehabilitation due to scarring.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003912
003      
CZ-PrNML
005      
20250206104801.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12941-024-00752-w $2 doi
035    __
$a (PubMed)39385246
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kukla, Rudolf $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
245    10
$a Successful treatment of Keratitis caused by Mycobacterium chelonae and an overview of previous cases in Europe / $c R. Kukla, K. Nouzovska, L. Ryskova, P. Rozsivalova, I. Pavlik, P. Bostik
520    9_
$a INTRODUCTION AND PURPOSE: Mycobacterium (M.) chelonae is responsible for a half of relatively rare nontuberculous mycobacteria (NTM) keratitis. We report a case of M. chelonae keratitis in a woman following sclerocorneal suture extraction after cataract surgery. RESULTS: A 70-year-old woman presented with a red eye and corneal infiltration of her left eye six weeks following sclerocorneal suture extraction after an elective cataract surgery in another institute. She complained of a sharp, cutting pain and photophobia. Since initial corneal scrapes and conjunctival swabs proved no pathogen using culture and PCR methods, non-specific antibiotics and antifungal agents were administered. As keratitis was complicated by an inflammation in the anterior chamber and vitreous, samples of the vitreous fluid were sent for microbiologic examination. DNA of Epstein-Barr virus (EBV) was repeatedly detected. Since the intrastromal abscess had formed, corneal re-scrapings were performed and M. chelonae was detected using culture, MALDI-TOF MS and PCR methods. Therapy was changed to a combination of oral and topical clarithromycin, intravitreal, topical and intracameral amikacin, and oral and topical moxifloxacin. The successful therapy led to stabilization. The optical penetrating keratoplasty was performed and no signs of the infection recurrence were found. CONCLUSIONS: The diagnosis of nontuberculous mycobacterial keratitis is difficult and often delayed. An aggressive and prolonged antimicrobial therapy should include systemic and topical antibiotics. Surgical intervention in the form of corneal transplantation may be required in the active and nonresponsive infection. In the presented case this was necessary for visual rehabilitation due to scarring.
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a amikacin $x terapeutické užití $7 D000583
650    12
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a klarithromycin $x terapeutické užití $7 D017291
650    _2
$a fluorochinolony $x terapeutické užití $7 D024841
650    12
$a keratitida $x diagnóza $x farmakoterapie $x mikrobiologie $x chirurgie $7 D007634
650    12
$a moxifloxacin $x terapeutické užití $7 D000077266
650    12
$a Mycobacterium chelonae $x izolace a purifikace $7 D016926
650    12
$a atypické mykobakteriální infekce $x diagnóza $x farmakoterapie $x mikrobiologie $x chirurgie $7 D009165
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $7 D005060
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Nouzovska, Katerina $u Department of Ophthalmology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Department of Ophthalmology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
700    1_
$a Ryskova, Lenka $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
700    1_
$a Rozsivalova, Petra $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic $u Hospital Pharmacy, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic
700    1_
$a Pavlik, Ivo $u Faculty of Regional Development and International Studies, Mendel University in Brno, tr. Generala Piky 7, Brno, 61300, Czech Republic
700    1_
$a Bostik, Pavel $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic. pavel.bostik@lfhk.cuni.cz $u Institute of Clinical Microbiology, University Hospital, Sokolska 581, Hradec Kralove, 50005, Czech Republic. pavel.bostik@lfhk.cuni.cz $1 https://orcid.org/0000000326916458
773    0_
$w MED00008163 $t Annals of clinical microbiology and antimicrobials $x 1476-0711 $g Roč. 23, č. 1 (2024), s. 92
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39385246 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104756 $b ABA008
999    __
$a ok $b bmc $g 2263578 $s 1239919
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 23 $c 1 $d 92 $e 20241009 $i 1476-0711 $m Annals of clinical microbiology and antimicrobials $n Ann Clin Microbiol Antimicrob $x MED00008163
GRA    __
$a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a MH-CZ DRO (UHHK, 00179906) $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NU20-09-00114 $p Agentura Pro Zdravotnický Výzkum České Republiky
GRA    __
$a NU20-09-00114 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...